Precision Immunology – Talk Bio

Actionable Insights Powered by AI

Hillstar Bio Launches with $67M to Develop Precision Immunotherapies for Autoimmune Diseases

4 weeks ago talkbio0Tagged Autoimmune Diseases, Axial, Precision Immunology, Series, Spondylarthritis, T-Lymphocyte, TRBV9 gene

Precision immunology, autoimmune diseases, TRBV9+ T cells, axial spondyloarthritis, Series A funding

Alumis Secures Record-Breaking $259M Series C Financing for Precision Immunology Drug Development

1 year ago talkbio0Tagged Alumis, Drug Development, Precision Immunology, private biotech, Series C

Alumis, Series C funding, $259 million, Precision immunology, Drug development, Private biotech fundraise